Xuan-Mai Truong Thanh

Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results

Marianne Pavel, Jarosław B. Ćwikła, Catherine Lombard‐Bohas et al. · European Journal of Cancer · 2021 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study

Martyn Caplin, Marianne Pavel, Alexandria T. Phan et al. · Endocrine · 2020 · 81 citations · Full text

Medicine, Oncology, Pharmacology +12

SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice—development and results from a pilot study

Andrea Giustina, John S. Bevan, Marcello D. Bronstein et al. · Pituitary · 2015 · 75 citations · Full text

Pharmacy, Endocrinology, Internal Medicine +17

Evaluation of Nurse Preferences Between the Lanreotide Autogel New Syringe and the Octreotide Long-Acting Release Syringe: An International Simulated-Use Study (PRESTO)

Daphne T. Adelman, Xuan-Mai Truong Thanh, Marion Feuilly et al. · Advances in Therapy · 2020 · 21 citations · Full text

Medicine, Endocrinology, Oncology +13

Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study

Sara Pusceddu, Claudio Vernieri, Massimo Di Maïo et al. · Cancers · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17